These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23859630)

  • 1. Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry.
    Blasco H; Corcia P; Pradat PF; Bocca C; Gordon PH; Veyrat-Durebex C; Mavel S; Nadal-Desbarats L; Moreau C; Devos D; Andres CR; Emond P
    J Proteome Res; 2013 Aug; 12(8):3746-54. PubMed ID: 23859630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential CSF biomarkers in ALS.
    Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
    Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.
    Wuolikainen A; Jonsson P; Ahnlund M; Antti H; Marklund SL; Moritz T; Forsgren L; Andersen PM; Trupp M
    Mol Biosyst; 2016 Apr; 12(4):1287-98. PubMed ID: 26883206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS.
    Wuolikainen A; Moritz T; Marklund SL; Antti H; Andersen PM
    PLoS One; 2011 Apr; 6(4):e17947. PubMed ID: 21483737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
    Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
    J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
    Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J
    Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations.
    Wuolikainen A; Andersen PM; Moritz T; Marklund SL; Antti H
    Mol Genet Metab; 2012 Mar; 105(3):472-8. PubMed ID: 22264771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis?
    Chełstowska B; Kuźma-Kozakiewicz M
    Biomarkers; 2014 Nov; 19(7):571-7. PubMed ID: 25133306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
    Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
    Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis.
    Roos PM; Vesterberg O; Syversen T; Flaten TP; Nordberg M
    Biol Trace Elem Res; 2013 Feb; 151(2):159-70. PubMed ID: 23225075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS.
    Wuolikainen A; Hedenström M; Moritz T; Marklund SL; Antti H; Andersen PM
    Amyotroph Lateral Scler; 2009 Aug; 10(4):229-36. PubMed ID: 19412814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis.
    Nociti V; Frisullo G; Marti A; Luigetti M; Iorio R; Patanella AK; Bianco A; Tonali PA; Grillo RL; Sabatelli M; Batocchi AP
    J Neuroimmunol; 2010 Aug; 225(1-2):149-52. PubMed ID: 20510468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis?
    Mendonça DM; Martins SC; Higashi R; Muscara MN; Neto VM; Chimelli L; Martinez AM
    Amyotroph Lateral Scler; 2011 Mar; 12(2):144-7. PubMed ID: 21198418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis.
    Roos PM; Lierhagen S; Flaten TP; Syversen T; Vesterberg O; Nordberg M
    Exp Biol Med (Maywood); 2012 Jul; 237(7):803-10. PubMed ID: 22859739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication.
    Matsuishi T; Nagamitsu S; Shoji H; Itoh M; Takashima S; Iwaki T; Shida N; Yamashita Y; Sakai T; Kato H
    J Neural Transm (Vienna); 1999; 106(9-10):943-8. PubMed ID: 10599876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3.
    Yamamoto-Watanabe Y; Watanabe M; Jackson M; Akimoto H; Sugimoto K; Yasujima M; Wakasaya Y; Matsubara E; Kawarabayashi T; Harigaya Y; Lyndon AR; Shoji M
    Brain Res; 2010 Nov; 1361():140-5. PubMed ID: 20849835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.